ARAV logo

ARAV Aravive, Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$0.04
-0.01 (-13.39%)

Aravive, Inc. is a clinical-stage biopharmaceutical company, based in Houston, Texas, dedicated to discovering and developing innovative treatments for life-threatening illnesses such as cancer and fibrosis. The company's primary therapeutic candidate, batiraxcept, is an ultrahigh-affinity decoy protein engineered to disrupt the GAS6-AXL signaling pathway. This drug is currently progressing throug…

Market Cap: $2.95Maravive.com

Price

No data yet.

Social Signal Score

30
5d
31
1 mentions
30d
30
1 mentions
60d
30
1 mentions
90d
30
1 mentions
news: 1

Revenue

$2.76M
$0.00$13.33M$26.67M$40.00M
Dec 2013Sep 2023

Analyst Estimates

FY2025
$-0.25
$-0.69$-0.17
3 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Fredric N. Eshelman
Sector
Healthcare
Industry
Biotechnology
Employees
23
Beta
2.19
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
-90.45
aravive.com